Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1995 Feb;69(2):1059–1070. doi: 10.1128/jvi.69.2.1059-1070.1995

Virus-induced immunosuppression: immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression.

P Borrow 1, C F Evans 1, M B Oldstone 1
PMCID: PMC188677  PMID: 7815484

Abstract

Despite the clinical importance of virus-induced immunosuppression, how virus infection may lead to a generalized suppression of the host immune response is poorly understood. To elucidate the principles involved, we analyzed the mechanism by which a lymphocytic choriomeningitis virus (LCMV) variant produces a generalized immune suppression in its natural host, the mouse. Whereas adult mice inoculated intravenously with LCMV Armstrong rapidly clear the infection and remain immunocompetent, inoculation with the Armstrong-derived LCMV variant clone 13, which differs from its parent virus at only two amino acid positions, by contrast results in persistent infection and a generalized deficit in responsiveness to subsequent immune challenge. Here we show that the immune suppression induced by LCMV clone 13 is associated with a CD8-dependent loss of interdigitating dendritic cells from periarteriolar lymphoid sheaths in the spleen and, functionally, with a deficit in the ability of splenocytes from infected mice to stimulate the proliferation of naive T cells in a primary mixed lymphocyte reaction. Dendritic cells are not depleted in immunocompetent Armstrong-infected mice. LCMV Armstrong and clone 13 exhibit differences in their tropism within the spleen, with clone 13 causing a higher level of infection of antigen-presenting cells in the white pulp, including periarterial interdigitating dendritic cells, than Armstrong, thereby rendering these cells targets for destruction by the antiviral CD8+ cytotoxic T-lymphocyte response which is induced at early times following infection with either virus. Our findings illustrate the key role that virus tropism may play in determining pathogenicity and, further, document a mechanism for virus-induced immunosuppression which may contribute to the clinically important immune suppression associated with many virus infections, including human immunodeficiency virus type 1.

Full Text

The Full Text of this article is available as a PDF (2.6 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahmed R., Hahn C. S., Somasundaram T., Villarete L., Matloubian M., Strauss J. H. Molecular basis of organ-specific selection of viral variants during chronic infection. J Virol. 1991 Aug;65(8):4242–4247. doi: 10.1128/jvi.65.8.4242-4247.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ahmed R., Salmi A., Butler L. D., Chiller J. M., Oldstone M. B. Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J Exp Med. 1984 Aug 1;160(2):521–540. doi: 10.1084/jem.160.2.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ahmed R., Simon R. S., Matloubian M., Kolhekar S. R., Southern P. J., Freedman D. M. Genetic analysis of in vivo-selected viral variants causing chronic infection: importance of mutation in the L RNA segment of lymphocytic choriomeningitis virus. J Virol. 1988 Sep;62(9):3301–3308. doi: 10.1128/jvi.62.9.3301-3308.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Althage A., Odermatt B., Moskophidis D., Kündig T., Hoffman-Rohrer U., Hengartner H., Zinkernagel R. M. Immunosuppression by lymphocytic choriomeningitis virus infection: competent effector T and B cells but impaired antigen presentation. Eur J Immunol. 1992 Jul;22(7):1803–1812. doi: 10.1002/eji.1830220720. [DOI] [PubMed] [Google Scholar]
  5. Armstrong J. A., Horne R. Follicular dendritic cells and virus-like particles in AIDS-related lymphadenopathy. Lancet. 1984 Aug 18;2(8399):370–372. doi: 10.1016/s0140-6736(84)90540-3. [DOI] [PubMed] [Google Scholar]
  6. Austyn J. M., Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol. 1981 Oct;11(10):805–815. doi: 10.1002/eji.1830111013. [DOI] [PubMed] [Google Scholar]
  7. Beckford A. P., Kaschula R. O., Stephen C. Factors associated with fatal cases of measles. A retrospective autopsy study. S Afr Med J. 1985 Dec 7;68(12):858–863. [PubMed] [Google Scholar]
  8. Borrow P., Oldstone M. B. Characterization of lymphocytic choriomeningitis virus-binding protein(s): a candidate cellular receptor for the virus. J Virol. 1992 Dec;66(12):7270–7281. doi: 10.1128/jvi.66.12.7270-7281.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Borrow P., Tishon A., Oldstone M. B. Infection of lymphocytes by a virus that aborts cytotoxic T lymphocyte activity and establishes persistent infection. J Exp Med. 1991 Jul 1;174(1):203–212. doi: 10.1084/jem.174.1.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Breel M., Mebius R. E., Kraal G. Dendritic cells of the mouse recognized by two monoclonal antibodies. Eur J Immunol. 1987 Nov;17(11):1555–1559. doi: 10.1002/eji.1830171105. [DOI] [PubMed] [Google Scholar]
  11. Bruce J., Symington F. W., McKearn T. J., Sprent J. A monoclonal antibody discriminating between subsets of T and B cells. J Immunol. 1981 Dec;127(6):2496–2501. [PubMed] [Google Scholar]
  12. Buchmeier M. J., Welsh R. M., Dutko F. J., Oldstone M. B. The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv Immunol. 1980;30:275–331. doi: 10.1016/s0065-2776(08)60197-2. [DOI] [PubMed] [Google Scholar]
  13. Byrne J. A., Oldstone M. B. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J Virol. 1984 Sep;51(3):682–686. doi: 10.1128/jvi.51.3.682-686.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Clerici M., Landay A. L., Kessler H. A., Zajac R. A., Boswell R. N., Muluk S. C., Shearer G. M. Multiple patterns of alloantigen presenting/stimulating cell dysfunction in patients with AIDS. J Immunol. 1991 Apr 1;146(7):2207–2213. [PubMed] [Google Scholar]
  15. Cobbold S. P., Jayasuriya A., Nash A., Prospero T. D., Waldmann H. Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo. Nature. 1984 Dec 6;312(5994):548–551. doi: 10.1038/312548a0. [DOI] [PubMed] [Google Scholar]
  16. Cohen J. What causes the immune system collapse seen in AIDS? Science. 1993 May 28;260(5112):1256–1256. doi: 10.1126/science.8098551. [DOI] [PubMed] [Google Scholar]
  17. Crocker P. R., Gordon S. Mouse macrophage hemagglutinin (sheep erythrocyte receptor) with specificity for sialylated glycoconjugates characterized by a monoclonal antibody. J Exp Med. 1989 Apr 1;169(4):1333–1346. doi: 10.1084/jem.169.4.1333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Dutko F. J., Oldstone M. B. Genomic and biological variation among commonly used lymphocytic choriomeningitis virus strains. J Gen Virol. 1983 Aug;64(Pt 8):1689–1698. doi: 10.1099/0022-1317-64-8-1689. [DOI] [PubMed] [Google Scholar]
  19. Helbert M. R., L'age-Stehr J., Mitchison N. A. Antigen presentation, loss of immunological memory and AIDS. Immunol Today. 1993 Jul;14(7):340–344. doi: 10.1016/0167-5699(93)90232-A. [DOI] [PubMed] [Google Scholar]
  20. Hengel H., Lindner M., Wagner H., Heeg K. Frequency of herpes simplex virus-specific murine cytotoxic T lymphocyte precursors in mitogen- and antigen-driven primary in vitro T cell responses. J Immunol. 1987 Dec 15;139(12):4196–4202. [PubMed] [Google Scholar]
  21. Horohov D. W., Rouse B. T. Virus-induced immunosuppression. Vet Clin North Am Small Anim Pract. 1986 Nov;16(6):1097–1127. doi: 10.1016/s0195-5616(86)50131-5. [DOI] [PubMed] [Google Scholar]
  22. Inaba K., Steinman R. M. Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine release. J Exp Med. 1984 Dec 1;160(6):1717–1735. doi: 10.1084/jem.160.6.1717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. King C. C., Jamieson B. D., Reddy K., Bali N., Concepcion R. J., Ahmed R. Viral infection of the thymus. J Virol. 1992 May;66(5):3155–3160. doi: 10.1128/jvi.66.5.3155-3160.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kohler M., Rüttner B., Cooper S., Hengartner H., Zinkernagel R. M. Enhanced tumor susceptibility of immunocompetent mice infected with lymphocytic choriomeningitis virus. Cancer Immunol Immunother. 1990;32(2):117–124. doi: 10.1007/BF01754208. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kraal G., Breel M., Janse M., Bruin G. Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody. J Exp Med. 1986 Apr 1;163(4):981–997. doi: 10.1084/jem.163.4.981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kraal G., Rep M., Janse M. Macrophages in T and B cell compartments and other tissue macrophages recognized by monoclonal antibody MOMA-2. An immunohistochemical study. Scand J Immunol. 1987 Dec;26(6):653–661. doi: 10.1111/j.1365-3083.1987.tb02301.x. [DOI] [PubMed] [Google Scholar]
  27. Langhoff E., Steinman R. M. Clonal expansion of human T lymphocytes initiated by dendritic cells. J Exp Med. 1989 Jan 1;169(1):315–320. doi: 10.1084/jem.169.1.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Leist T. P., Rüedi E., Zinkernagel R. M. Virus-triggered immune suppression in mice caused by virus-specific cytotoxic T cells. J Exp Med. 1988 May 1;167(5):1749–1754. doi: 10.1084/jem.167.5.1749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lo D., Reilly C. R., Scott B., Liblau R., McDevitt H. O., Burkly L. C. Antigen-presenting cells in adoptively transferred and spontaneous autoimmune diabetes. Eur J Immunol. 1993 Jul;23(7):1693–1698. doi: 10.1002/eji.1830230744. [DOI] [PubMed] [Google Scholar]
  30. Macatonia S. E., Gompels M., Pinching A. J., Patterson S., Knight S. C. Antigen-presentation by macrophages but not by dendritic cells in human immunodeficiency virus (HIV) infection. Immunology. 1992 Apr;75(4):576–581. [PMC free article] [PubMed] [Google Scholar]
  31. Macatonia S. E., Lau R., Patterson S., Pinching A. J., Knight S. C. Dendritic cell infection, depletion and dysfunction in HIV-infected individuals. Immunology. 1990 Sep;71(1):38–45. [PMC free article] [PubMed] [Google Scholar]
  32. Matloubian M., Kolhekar S. R., Somasundaram T., Ahmed R. Molecular determinants of macrophage tropism and viral persistence: importance of single amino acid changes in the polymerase and glycoprotein of lymphocytic choriomeningitis virus. J Virol. 1993 Dec;67(12):7340–7349. doi: 10.1128/jvi.67.12.7340-7349.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. McChesney M. B., Oldstone M. B. Virus-induced immunosuppression: infections with measles virus and human immunodeficiency virus. Adv Immunol. 1989;45:335–380. doi: 10.1016/s0065-2776(08)60696-3. [DOI] [PubMed] [Google Scholar]
  34. Merson M. H. Slowing the spread of HIV: agenda for the 1990s. Science. 1993 May 28;260(5112):1266–1268. doi: 10.1126/science.8493570. [DOI] [PubMed] [Google Scholar]
  35. Metlay J. P., Witmer-Pack M. D., Agger R., Crowley M. T., Lawless D., Steinman R. M. The distinct leukocyte integrins of mouse spleen dendritic cells as identified with new hamster monoclonal antibodies. J Exp Med. 1990 May 1;171(5):1753–1771. doi: 10.1084/jem.171.5.1753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Mims C. A. Interactions of viruses with the immune system. Clin Exp Immunol. 1986 Oct;66(1):1–16. [PMC free article] [PubMed] [Google Scholar]
  37. Moskophidis D., Pircher H., Ciernik I., Odermatt B., Hengartner H., Zinkernagel R. M. Suppression of virus-specific antibody production by CD8+ class I-restricted antiviral cytotoxic T cells in vivo. J Virol. 1992 Jun;66(6):3661–3668. doi: 10.1128/jvi.66.6.3661-3668.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Murphy F. A., Buchmeier M. J., Rawls W. E. The reticuloendothelium as the target in a virus infection. Pichinde virus pathogenesis in two strains of hamsters. Lab Invest. 1977 Nov;37(5):502–515. [PubMed] [Google Scholar]
  39. Nussenzweig M. C., Steinman R. M., Witmer M. D., Gutchinov B. A monoclonal antibody specific for mouse dendritic cells. Proc Natl Acad Sci U S A. 1982 Jan;79(1):161–165. doi: 10.1073/pnas.79.1.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Odermatt B., Eppler M., Leist T. P., Hengartner H., Zinkernagel R. M. Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):8252–8256. doi: 10.1073/pnas.88.18.8252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Oldstone M. B. Immunotherapy for virus infection. Curr Top Microbiol Immunol. 1987;134:211–229. doi: 10.1007/978-3-642-71726-0_9. [DOI] [PubMed] [Google Scholar]
  42. Oldstone M. B. Molecular anatomy of viral persistence. J Virol. 1991 Dec;65(12):6381–6386. doi: 10.1128/jvi.65.12.6381-6386.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Oldstone M. B., Tishon A., Chiller J. M., Weigle W. O., Dixon F. J. Effect of chronic viral infection on the immune system. I. Comparison of the immune responsiveness of mice chronically infected with LCM virus with that of noninfected mice. J Immunol. 1973 May;110(5):1268–1278. [PubMed] [Google Scholar]
  44. Oldstone M. B. Viral persistence. Cell. 1989 Feb 24;56(4):517–520. doi: 10.1016/0092-8674(89)90573-4. [DOI] [PubMed] [Google Scholar]
  45. Ozato K., Sachs D. H. Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression. J Immunol. 1981 Jan;126(1):317–321. [PubMed] [Google Scholar]
  46. Parekh B. S., Buchmeier M. J. Proteins of lymphocytic choriomeningitis virus: antigenic topography of the viral glycoproteins. Virology. 1986 Sep;153(2):168–178. doi: 10.1016/0042-6822(86)90020-6. [DOI] [PubMed] [Google Scholar]
  47. Pircher H., Bürki K., Lang R., Hengartner H., Zinkernagel R. M. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature. 1989 Nov 30;342(6249):559–561. doi: 10.1038/342559a0. [DOI] [PubMed] [Google Scholar]
  48. Riviere Y., Ahmed R., Southern P. J., Buchmeier M. J., Dutko F. J., Oldstone M. B. The S RNA segment of lymphocytic choriomeningitis virus codes for the nucleoprotein and glycoproteins 1 and 2. J Virol. 1985 Mar;53(3):966–968. doi: 10.1128/jvi.53.3.966-968.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Roost H., Charan S., Gobet R., Rüedi E., Hengartner H., Althage A., Zinkernagel R. M. An acquired immune suppression in mice caused by infection with lymphocytic choriomeningitis virus. Eur J Immunol. 1988 Apr;18(4):511–518. doi: 10.1002/eji.1830180404. [DOI] [PubMed] [Google Scholar]
  50. Rüedi E., Hengartner H., Zinkernagel R. M. Immunosuppression in mice by lymphocytic choriomeningitis virus infection: time dependence during primary and absence of effects on secondary antibody responses. Cell Immunol. 1990 Oct 15;130(2):501–512. doi: 10.1016/0008-8749(90)90290-8. [DOI] [PubMed] [Google Scholar]
  51. Salvato M. S., Shimomaye E. M. The completed sequence of lymphocytic choriomeningitis virus reveals a unique RNA structure and a gene for a zinc finger protein. Virology. 1989 Nov;173(1):1–10. doi: 10.1016/0042-6822(89)90216-x. [DOI] [PubMed] [Google Scholar]
  52. Salvato M., Borrow P., Shimomaye E., Oldstone M. B. Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence. J Virol. 1991 Apr;65(4):1863–1869. doi: 10.1128/jvi.65.4.1863-1869.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Salvato M., Shimomaye E., Southern P., Oldstone M. B. Virus-lymphocyte interactions. IV. Molecular characterization of LCMV Armstrong (CTL+) small genomic segment and that of its variant, Clone 13 (CTL-). Virology. 1988 Jun;164(2):517–522. doi: 10.1016/0042-6822(88)90566-1. [DOI] [PubMed] [Google Scholar]
  54. Southern P. J., Singh M. K., Riviere Y., Jacoby D. R., Buchmeier M. J., Oldstone M. B. Molecular characterization of the genomic S RNA segment from lymphocytic choriomeningitis virus. Virology. 1987 Mar;157(1):145–155. doi: 10.1016/0042-6822(87)90323-0. [DOI] [PubMed] [Google Scholar]
  55. Sprent J., Schaefer M. Properties of purified T cell subsets. I. In vitro responses to class I vs. class II H-2 alloantigens. J Exp Med. 1985 Dec 1;162(6):2068–2088. doi: 10.1084/jem.162.6.2068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Steinman R. M. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol. 1991;9:271–296. doi: 10.1146/annurev.iy.09.040191.001415. [DOI] [PubMed] [Google Scholar]
  57. Tenner-Rácz K., Rácz P., Dietrich M., Kern P. Altered follicular dendritic cells and virus-like particles in AIDS and AIDS-related lymphadenopathy. Lancet. 1985 Jan 12;1(8420):105–106. doi: 10.1016/s0140-6736(85)91994-4. [DOI] [PubMed] [Google Scholar]
  58. Tishon A., Borrow P., Evans C., Oldstone M. B. Virus-induced immunosuppression. 1. Age at infection relates to a selective or generalized defect. Virology. 1993 Aug;195(2):397–405. doi: 10.1006/viro.1993.1389. [DOI] [PubMed] [Google Scholar]
  59. Wright K. E., Buchmeier M. J. Antiviral antibodies attenuate T-cell-mediated immunopathology following acute lymphocytic choriomeningitis virus infection. J Virol. 1991 Jun;65(6):3001–3006. doi: 10.1128/jvi.65.6.3001-3006.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Wu-Hsieh B., Howard D. H., Ahmed R. Virus-induced immunosuppression: a murine model of susceptibility to opportunistic infection. J Infect Dis. 1988 Jul;158(1):232–235. doi: 10.1093/infdis/158.1.232. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES